Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hartigan-Go

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Australian Health Review : a Publication of the Australian Hospital Association|August 11, 2001
The pharmaceutical situation in the PhilippinesK Hartigan-Go
Human & Experimental Toxicology|December 1, 1994
Redtide in the PhilippinesK Hartigan-Go, D N Bateman
Journal of Toxicology. Clinical Toxicology|January 1, 1997
Position statement: cathartics. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical ToxicologistsD Barceloux, M McGuigan, K Hartigan-Go
British Journal of Clinical Pharmacology|January 1, 1996
Effect of oxybutynin on the QTc interval in elderly patients with urinary incontinenceR M Hussain, K Hartigan-Go, S H Thomas, et al.
Clinical Pharmacology and Therapeutics|July 1, 1996
Stereoselective cardiotoxic effects of terodilineK Hartigan-Go, D N Bateman, A K Daly, et al.
Bulletin of the World Health Organization|October 6, 2000
Developing an immunization safety surveillance system in the PhilippinesK Hartigan-Go, M C Roces, C A Habacon, et al.
Clinical Pharmacology and Therapeutics|November 1, 1996
Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humansK Hartigan-Go, D N Bateman, G Nyberg, et al.
British Heart Journal|July 1, 1995
Concentration dependent cardiotoxicity of terodiline in patients treated for urinary incontinenceS H Thomas, P D Higham, K Hartigan-Go, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Australian Health Review : a Publication of the Australian Hospital Association|August 11, 2001
The pharmaceutical situation in the PhilippinesK Hartigan-Go
Human & Experimental Toxicology|December 1, 1994
Redtide in the PhilippinesK Hartigan-Go, D N Bateman
Journal of Toxicology. Clinical Toxicology|January 1, 1997
Position statement: cathartics. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical ToxicologistsD Barceloux, M McGuigan, K Hartigan-Go
British Journal of Clinical Pharmacology|January 1, 1996
Effect of oxybutynin on the QTc interval in elderly patients with urinary incontinenceR M Hussain, K Hartigan-Go, S H Thomas, et al.
Clinical Pharmacology and Therapeutics|July 1, 1996
Stereoselective cardiotoxic effects of terodilineK Hartigan-Go, D N Bateman, A K Daly, et al.
Bulletin of the World Health Organization|October 6, 2000
Developing an immunization safety surveillance system in the PhilippinesK Hartigan-Go, M C Roces, C A Habacon, et al.
Clinical Pharmacology and Therapeutics|November 1, 1996
Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humansK Hartigan-Go, D N Bateman, G Nyberg, et al.
British Heart Journal|July 1, 1995
Concentration dependent cardiotoxicity of terodiline in patients treated for urinary incontinenceS H Thomas, P D Higham, K Hartigan-Go, et al.
Pageof 1